1. Home
  2. ACRE vs ARMP Comparison

ACRE vs ARMP Comparison

Compare ACRE & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ares Commercial Real Estate Corporation

ACRE

Ares Commercial Real Estate Corporation

N/A

Current Price

$3.68

Market Cap

191.4M

Sector

Real Estate

ML Signal

N/A

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

N/A

Current Price

$3.38

Market Cap

199.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ACRE
ARMP
Founded
2011
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
191.4M
199.7M
IPO Year
2011
1996

Fundamental Metrics

Financial Performance
Metric
ACRE
ARMP
Price
$3.68
$3.38
Analyst Decision
Hold
Strong Buy
Analyst Count
8
2
Target Price
$5.00
★ $17.50
AVG Volume (30 Days)
★ 648.5K
87.6K
Earning Date
11-06-2026
11-20-2026
Dividend Yield
★ 17.65%
N/A
EPS Growth
★ 26.17
N/A
EPS
★ 1.35
N/A
Revenue
★ $54,833,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.53
N/A
P/E Ratio
$2.60
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$3.16
$2.75
52 Week High
$5.89
$14.98

Technical Indicators

Market Signals
Indicator
ACRE
ARMP
Relative Strength Index (RSI) 58.05 45.21
Support Level N/A $2.75
Resistance Level $4.98 $3.96
Average True Range (ATR) 0.15 0.34
MACD 0.06 0.03
Stochastic Oscillator 84.46 37.49

Price Performance

Historical Comparison
ACRE
ARMP

About ACRE Ares Commercial Real Estate Corporation

Ares Commercial Real Estate Corp is a specialty finance company and a real estate investment trust mainly engaged in originating and investing in commercial real estate (CRE) loans and related investments. It operates in one segment, namely originating and managing a diversified portfolio of CRE debt-related investments. The company recognizes the majority of its revenues in the form of interest income, which it receives from loans.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

Share on Social Networks: